Expression patterns and prognostic value of N6-methyladenosine regulators in esophageal cancer
Introduction: Aberrant m6A regulators contribute to esophageal cancer, yet few studies stratify by subtype and compare prognostic models. Objectives: N6-methyladenosine (m6A) modification broadly regulates cancer progression and prognosis, while its clinical role in esophageal cancer (EC) remains poorly defined. Method...